Insider · CIK 0002021679
Naimish Patel
Files at CRSP (CRISPR Therapeutics AG), AGMB (AgomAb Therapeutics NV). First filing May 30, 2025, latest May 30, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CRSP: CRISPR Therapeutics AG
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 21Weak | CRSPsell CRISPR Therapeutics AG | $141k 3,932 shares | -39% | +18% from low-33% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | AGMB AgomAb Therapeutics NV | AGrant or award Stock Option (Right to Buy)derivative | +56,328 | $0.00 | $0 | 56,328 | 27 d ago |
| May 30, 2025 | CRSP CRISPR Therapeutics AG | AGrant or award Restricted Stock Unitsderivative | +25,000 | $0.00 | $0 | 25,000 | Jun 3, 2025 |
| May 28, 2025 | CRSP CRISPR Therapeutics AG | MOption exercise Common Shares | +10,000 | - | - | 10,000 | May 30, 2025 |
| May 29, 2025 | CRSP CRISPR Therapeutics AG | SOpen-market sale Common Shares | -3,932 | $35.94 | $141k | 6,068 | May 30, 2025 |
| May 28, 2025 | CRSP CRISPR Therapeutics AG | MOption exercise Restricted Stock Unitsderivative | -10,000 | - | - | 30,000 | May 30, 2025 |
| Mar 14, 2025 | CRSP CRISPR Therapeutics AG | AGrant or award Stock Option (Right to Buy)derivative | +46,667 | $0.00 | $0 | 46,667 | Mar 18, 2025 |
| Mar 14, 2025 | CRSP CRISPR Therapeutics AG | AGrant or award Restricted Stock Unitsderivative | +32,500 | $0.00 | $0 | 32,500 | Mar 18, 2025 |
| Oct 16, 2024 | CRSP CRISPR Therapeutics AG | AGrant or award Stock Option (Right to Buy)derivative | +18,333 | $0.00 | $0 | 18,333 | Oct 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.